The global Artificial Urinary Sphincters Market is expanding as the prevalence of urinary incontinence increases among aging populations and as healthcare providers seek advanced solutions for severe stress urinary incontinence. Artificial urinary sphincters are implantable devices designed to restore urinary control, particularly among patients experiencing incontinence following prostate surgery, neurological disorders, pelvic-floor dysfunction, or other conditions affecting the urinary sphincter.

According to Fortune Business Insights, the global artificial urinary sphincters market was valued at USD 616.9 million in 2025 and is projected to grow from USD 661.41 million in 2026 to USD 1,154.79 million by 2034, exhibiting a CAGR of 7.21% during the forecast period.

Why is the Artificial Urinary Sphincters Market Growing?

The increasing number of patients experiencing severe urinary incontinence, particularly following prostate-related procedures, is a major factor driving demand. Artificial urinary sphincters provide an implant-based option for patients whose symptoms remain significant despite conservative management.

Artificial urinary sphincters are increasingly used for:

• Severe stress urinary incontinence
• Post-prostatectomy incontinence
• Neurological urinary dysfunction
• Pelvic-floor dysfunction
• Long-term continence restoration
• Refractory urinary incontinence
• Continence management following prostate procedures

Increasing awareness of advanced continence-restoration therapies and improving access to specialized urology services are further supporting adoption.

Key Market Trends Shaping Industry Growth

Increasing Prevalence of Urinary Incontinence

Aging populations, neurological disorders, prostate disease, spinal injuries, and pelvic-floor disorders are contributing to a growing population requiring continence-management solutions.

Growing Number of Prostate Cancer Procedures

The increasing number of prostate cancer treatments and prostate surgeries is generating demand for post-procedure urinary continence therapies. The U.S. market is particularly influenced by prostate cancer treatment and awareness of continence-restoration options.

Increasing Adoption of Minimally Invasive Implantation

Urologists are increasingly adopting less invasive implantation techniques that can potentially reduce surgical trauma and support faster recovery.